RecruitingNot ApplicableNCT07177482

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

Sponsor

Deling Li

Enrollment

20 participants

Start Date

Jul 4, 2025

Study Type

INTERVENTIONAL

Conditions

Craniopharyngioma

Summary

This study aims to investigate 68Ga-MY6349, an immune-PET tracer targeting trophoblast cell surface antigen 2 (Trop2), for the noninvasive diagnosis of craniopharyngioma in vivo.

Eligibility

Min Age: 14 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 68Ga-MY6349 PET/CT for people with craniopharyngioma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.